These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20340136)

  • 61. Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy.
    Xu L; Cheng Z; Cui C; Wu X; Yu H; Guo J; Kong Y
    J Transl Med; 2019 Jul; 17(1):245. PubMed ID: 31358010
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases.
    Aoude LG; Gartside M; Johansson P; Palmer JM; Symmons J; Martin NG; Montgomery GW; Hayward NK
    Twin Res Hum Genet; 2015 Apr; 18(2):126-33. PubMed ID: 25787093
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.
    Young RJ; Waldeck K; Martin C; Foo JH; Cameron DP; Kirby L; Do H; Mitchell C; Cullinane C; Liu W; Fox SB; Dutton-Regester K; Hayward NK; Jene N; Dobrovic A; Pearson RB; Christensen JG; Randolph S; McArthur GA; Sheppard KE
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):590-600. PubMed ID: 24495407
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A).
    Li J; Muscarella P; Joo SH; Knobloch TJ; Melvin WS; Weghorst CM; Tsai MD
    Biochemistry; 2005 Oct; 44(40):13246-56. PubMed ID: 16201750
    [TBL] [Abstract][Full Text] [Related]  

  • 65. p16(Ink4a) in melanocyte senescence and differentiation.
    Sviderskaya EV; Hill SP; Evans-Whipp TJ; Chin L; Orlow SJ; Easty DJ; Cheong SC; Beach D; DePinho RA; Bennett DC
    J Natl Cancer Inst; 2002 Mar; 94(6):446-54. PubMed ID: 11904317
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas.
    Cabanillas R; Astudillo A; Valle M; de la Rosa J; Álvarez R; Durán NS; Cadiñanos J
    Head Neck; 2013 Mar; 35(3):E80-4. PubMed ID: 22083977
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments.
    Witkiewicz AK; Knudsen KE; Dicker AP; Knudsen ES
    Cell Cycle; 2011 Aug; 10(15):2497-503. PubMed ID: 21775818
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The melanoma-associated 24 base pair duplication in p16INK4a is functionally impaired.
    Becker TM; Ayub AL; Kefford RF; Mann GJ; Rizos H
    Int J Cancer; 2005 Nov; 117(4):569-73. PubMed ID: 15945100
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
    FitzGerald MG; Harkin DP; Silva-Arrieta S; MacDonald DJ; Lucchina LC; Unsal H; O'Neill E; Koh J; Finkelstein DM; Isselbacher KJ; Sober AJ; Haber DA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8541-5. PubMed ID: 8710906
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines.
    McLaughlin-Drubin ME; Park D; Munger K
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16175-80. PubMed ID: 24046371
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Wild type and melanoma-associated mutant p16(IN4a) proteins do not oligomerize in vivo.
    McKenzie H; Becker TM; Scurr LL; Kefford RF; Rizos H
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):131-3. PubMed ID: 19154236
    [No Abstract]   [Full Text] [Related]  

  • 72. Melanoma development in relation to non-functional p16/INK4A protein and dysplastic naevus syndrome in Swedish melanoma kindreds.
    Hashemi J; Linder S; Platz A; Hansson J
    Melanoma Res; 1999 Feb; 9(1):21-30. PubMed ID: 10338331
    [TBL] [Abstract][Full Text] [Related]  

  • 73. eMelanoBase: an online locus-specific variant database for familial melanoma.
    Fung DC; Holland EA; Becker TM; Hayward NK; Bressac-de Paillerets B; Mann GJ;
    Hum Mutat; 2003 Jan; 21(1):2-7. PubMed ID: 12497626
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of a CDK4 R24H mutation-positive melanoma family by analysis of early-onset melanoma patients in Latvia.
    Pjanova D; Molven A; Akslen LA; Engele L; Streinerte B; Azarjana K; Heisele O
    Melanoma Res; 2009 Apr; 19(2):119-22. PubMed ID: 19238106
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARF.
    Hashemi J; Lindström MS; Asker C; Platz A; Hansson J; Wiman KG
    Cancer Lett; 2002 Jun; 180(2):211-21. PubMed ID: 12175554
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The expression of p16(INK4a), the product of a tumor suppressor gene for melanoma, is upregulated in human melanocytes by UVB irradiation.
    Piepkorn M
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):741-5. PubMed ID: 10775848
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Absence of R24C mutation of the CDK4 gene in leukemias and solid tumors.
    Mori N; Yang R; Kawamata N; Miller CW; Mizoguchi H; Koeffler HP
    Int J Hematol; 2003 Apr; 77(3):259-62. PubMed ID: 12731669
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structural consequences of tumor-derived mutations in p16INK4a probed by limited proteolysis.
    Zhang B; Peng ZY
    Biochemistry; 2002 May; 41(20):6293-302. PubMed ID: 12009890
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression and characterization of Syrian golden hamster p16, a homologue of human tumor suppressor p16 INK4A.
    Li J; Qin D; Knobloch TJ; Tsai MD; Weghorst CM; Melvin WS; Muscarella P
    Biochem Biophys Res Commun; 2003 May; 304(2):241-7. PubMed ID: 12711305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular dynamics simulations and statistical coupling analysis reveal functional coevolution network of oncogenic mutations in the CDKN2A-CDK6 complex.
    Wang J; Zhao Y; Wang Y; Huang J
    FEBS Lett; 2013 Jan; 587(2):136-41. PubMed ID: 23178718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.